Nautilus Biotechnology Inc (NAUT) Stock Analysis

Nautilus Biotechnology Inc (NAUT) is a publicly traded company in the HEALTHCARE sector. It trades at $2.68, carries a market capitalization of $348.20M. This page summarizes the public market data, fundamentals, and frequently asked questions for NAUT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Nautilus Biotechnology Inc currently has a Bullish sentiment score of 0.51.

About Nautilus Biotechnology Inc

Nautilus Biotechnology Inc. is a cutting-edge life sciences company located in Seattle, Washington, dedicated to transforming proteomics with its advanced platform technology. As a development-stage firm, Nautilus aims to enhance the understanding of protein dynamics, which is critical for elucidating biological processes and underlying disease mechanisms. By addressing the intricate complexities of the proteome, Nautilus is well-positioned to facilitate breakthroughs in drug discovery and pe...

GNG Research Analysis

GNG Research scores Nautilus Biotechnology Inc (NAUT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NAUT.

Frequently Asked Questions

Does NAUT pay dividends?

Nautilus Biotechnology Inc (NAUT) does not currently pay a regular dividend.

What is NAUT's market cap?

Nautilus Biotechnology Inc (NAUT) has a market capitalization of $348.20M with a current stock price of $2.68.